Skip to main content

Table 4 Association between metformin, dipeptidyl peptidase-4 inhibitors, insulin, and metformin plus dipeptidyl peptidase-4 inhibitors and study outcomes before propensity score matching

From: Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study

Outcomes

Treatment groups

Univariate model

Multivariate model

OR (95% CI)

p value

OR (95% CI)

p value

 

Metformin (n = 825)

Other GLD (n = 663)

p value

 

In-hospital deaths

244 (29.6%)

244 (36.8%)

0.005

0.73 (0.58–0.90)

0.004

1.10 (0.76–1.60)

0.616

ICU admission, mechanical ventilation, or in-hospital death

295 (35.8%)

278 (41.9%)

0.023

0.78 (0.63–0.96)

0.020

1.03 (0.73–1.44)

0.883

In-hospital complications

435 (52.7%)

394 (59.4%)

0.013

0.76 (0.62–0.94)

0.011

1.08 (0.77–1.50)

0.666

Long-time hospital stay

195 (23.6%)

149 (22.5%)

0.584

1.08 (0.85–1.38)

0.542

1.41 (0.96–2.09)

0.080

 

DPP-4i (n = 180)

Other GLD (n = 1409)

p value

 

In-hospital deaths

75 (41.7%)

440 (31.2%)

0.007

1.56 (1.13–2.14)

0.006

1.39 (0.64–1.67)

0.876

ICU admission, mechanical ventilation, or in-hospital death

80 (44.4%)

531 (37.7%)

0.119

1.30 (0.95–1.78)

0.102

0.97 (0.61–1.52)

0.890

In-hospital complications

113 (62.8%)

775 (55.0%)

0.104

1.33 (0.96–1.84)

0.089

0.95 (0.59–1.54)

0.842

Long-time hospital stay

35 (19.4%)

321 (22.8%)

0.333

0.81 (0.54–1.18)

0.288

0.90 (0.52–1.52)

0.703

Insulin (n = 292)

Other GLD (n = 1458)

p value

 

In-hospital deaths

111 (38.0%)

431 (29.6%)

0.007

1.45 (1.11–1.88)

0.006

1.11 (0.70–1.75)

0.652

ICU admission, mechanical ventilation, or in-hospital death

125 (42.8%)

528 (36.2%)

0.039

1.32 (1.02–1.71)

0.033

1.09 (0.71–1.66)

0.699

In-hospital complications

170 (58.2%)

786 (53.9%)

0.143

1.23 (0.95–1.60)

0.126

0.96 (0.62–1.47)

0.834

Long-time hospital stay

74 (25.3%)

327 (22.4%)

0.357

1.16 (0.86–1.55)

0.318

0.699 (0.43–1.12)

0.145

Metformin + DPP-4i (n = 288)

Other GLD (n = 384)

p value

 

In-hospital deaths

80 (27.8%)

136 (35.4%)

0.044

0.70 (0.50–0.98)

0.036

0.71 (0.40–1.28)

0.257

ICU admission, mechanical ventilation, or in-hospital death

104 (36.1%)

159 (41.4%)

0.159

0.79 (0.57–1.08)

0.137

0.82 (0.50–1.36)

0.452

In-hospital complications

160 (55.6%)

226 (58.9%)

0.304

0.84 (0.61–1.15)

0.268

1.01 (0.63–1.62)

0.975

Long-time hospital stay

71 (24.7%)

95 (24.7%)

1.000

1.00 (0.71–1.44)

0.963

1.42 (0.82–2.47)

0.217

  1. Data are shown as absolute values and percentages. Values were considered to be statistically significant when p < 0.05
  2. DPP-4i dipeptidyl peptidase-4 inhibitors, GLD glucose-lowering drugs, ICU intensive care unit, OR odds ratio, 95% CI 95% confidence interval